The unprecedented public health and economic impact of the COVID-19 pandemic caused
by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been …

SARS-CoV-2 variants with spike (S)-protein D614G mutations now predominate globally.
We therefore compare the properties of the mutated S protein (S G614 ) with the original (S …

SARS coronavirus 2 (SARS-CoV-2) isolates encoding a D614G mutation in the viral spike (S)
protein predominate over time in locales where it is found, implying that this change …

During the COVID-19 pandemic, Pfizer-BioNTech and Moderna successfully developed
nucleoside-modified mRNA lipid nanoparticle (LNP) vaccines. SARS-CoV-2 spike protein …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped virus which
binds its cellular receptor angiotensin-converting enzyme 2 (ACE2) and enters hosts cells …

CD4 + T cells are tightly regulated by microbiota in the intestine, but whether intestinal T cells
interface with host-derived metabolites is less clear. Here, we show that CD4 + T effector (…

Arbidol (ARB) is a broad-spectrum antiviral drug approved in Russia and China for the
treatment of influenza. ARB was tested in patients as a drug candidate for the treatment at the …

Preexisting immunity against dengue virus or West Nile virus was previously reported to
mediate antibody-dependent enhancement (ADE) of Zika virus (ZIKV) infection in a mouse …

Phosphatidylserine (PS) receptors mediate clearance of apoptotic cells—efferocytosis—by
recognizing the PS exposed on those cells. They also mediate the entry of enveloped viruses …

Adeno-associated virus (AAV) is one of the most commonly used vectors for gene therapy,
and the applications for AAV-delivered therapies are numerous. However, the current state of …